Clinical and economic outcomes associated with the use of specific potentially inappropriate medications in the elderly were evaluated.
Lisa Le, MS
Advertisement
Articles by Lisa Le, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
2
5 FAQs: Ebola Outbreaks and the Challenge of Public Trust
3
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
4
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
5